首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Advances in tetrahydropyrido[1,2-a]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitors
【24h】

Advances in tetrahydropyrido[1,2-a]isoindolone (valmerins) series: Potent glycogen synthase kinase 3 and cyclin dependent kinase 5 inhibitors

机译:四氢吡啶并[1,2-a]异吲哚酮(valmerins)系列的研究进展:强大的糖原合酶激酶3和细胞周期蛋白依赖性激酶5抑制剂

获取原文
获取原文并翻译 | 示例
       

摘要

An efficient synthetic strategy was developed to modulate the structure of the tetrahydropyridine iso-indolone (Valmerin) skeleton. A library of more than 30 novel final structures was generated. Biological activities on CDK5 and GSM as well as cellular effects on cancer cell lines were measured for each novel compound. Additionally docking studies were performed to support medicinal chemistry efforts. A strong GSK3/CDK5 dual inhibitor (38, IC50 GSK3/CDK5 32/84 nM) was obtained. A set of highly selective GSK3 inhibitors was synthesized by fine-tuning structural modifications (29 IC50 GSK3/CDK5 32/320 nM). Antiproliferative effects on cells were correlated with the in vitro Kinase activities and the best effects were obtained with lung and colon cell lines. (C) 2015 Elsevier Masson SAS. All rights reserved.
机译:开发了一种有效的合成策略来调节四氢吡啶异吲哚酮(Valmerin)骨架的结构。生成了30多个新颖的最终结构的库。对于每种新型化合物,都测量了CDK5和GSM的生物活性以及对癌细胞系的细胞作用。此外,还进行了对接研究以支持药物化学工作。获得了强力的GSK3 / CDK5双重抑制剂(38,IC50 GSK3 / CDK5 32/84 nM)。通过微调结构修饰(29 IC50 GSK3 / CDK5 32/320 nM)合成了一组高选择性GSK3抑制剂。对细胞的抗增殖作用与体外激酶活性相关,而肺和结肠细胞系获得的最佳作用。 (C)2015 Elsevier Masson SAS。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号